ArticleJournal of gastroenterology2026
Mucin phenotype stratifies histological malignancy in superficial non-ampullary duodenal epithelial tumors: a prospective study.
Article in Journal of gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSuperficial non-ampullary duodenal epithelial tumors (SNADETs) are being increasingly detected during routine endoscopy. However, biological malignancy and optimal risk stratification remain poorly defined. We aimed to clarify the association between mucin phenotypes and histological malignancies in SNADETs using a prospective study design.
methodsIn this prospective observational study, patients with suspected SNADETs underwent a standardized magnified endoscopic examination with image-enhanced endoscopy (IEE-ME), followed by endoscopic resection. All specimens were centrally reviewed by expert gastrointestinal pathologists. Mucin phenotypes were classified as G type (gastric, predominantly gastric, or mixed) or I type (intestinal or predominantly intestinal). Histological malignancy was assessed using the Vienna classification (VCL). Clinicopathological and endoscopic factors associated with mucin phenotype and malignancy were systematically analyzed.
resultsAmong the 401 SNADETs, adenomas were predominant (72.1%), whereas submucosal invasive cancers were rare (2.5%). G-type SNADETs comprised 15.5% of lesions but demonstrated a markedly higher frequency beyond VCL category 4.1 compared to I-type SNADETs (P < 0.0001). The risk of histological malignancy increased stepwise with the proportion of gastric phenotypic components. Most invasive submucosal cancers exhibit a gastric phenotype. Multivariate analysis of the endoscopic findings identified a closed-loop structure, the absence of a white opaque substance on IEE-ME, and protruding morphology as independent predictors of G-type SNADETs.
conclusionThe gastric phenotype is strongly associated with increased histological malignancy in SNADETs. Specific endoscopic features can predict G-type SNADETs, suggesting that mucin phenotype-oriented endoscopic diagnosis may provide useful information for pretreatment risk stratification and treatment planning.
Indexed as
Identifiers
42658244What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.